Daniel J. Landsburg

Hematology

3400 Civic Center Boulevard
West Pavilion, 4th Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Publisher Correction: Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Publisher Correction: Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Journal: Nature medicine

Published: August 26, 2026

Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.

Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas.

Journal: The New England journal of medicine

Published: June 24, 2026

Safe Integration of Radiation Therapy With Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas.

Safe Integration of Radiation Therapy With Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 30, 2026

An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404.

An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 09, 2026

Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden.

Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden.

Journal: Blood neoplasia

Published: February 09, 2026

Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma.

Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma.

Journal: International journal of particle therapy

Published: December 28, 2025

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Journal: Nature medicine

Published: December 18, 2025

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial.

Biomarker-Guided Cardioprotection for Patients Treated With Anthracyclines: A Randomized Clinical Trial.

Journal: JAMA network open

Published: December 03, 2025

Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.

Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2-3 trial.

Journal: The Lancet. Haematology

Published: November 17, 2025

Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance.

Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance.

Journal: Cancer medicine

Published: November 06, 2025

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: October 09, 2025

Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma.

Prognostic impact of TP53 alterations in cases of newly diagnosed large B-cell lymphoma.

Journal: Leukemia

Published: September 02, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026